NURTEC ODT

This brand name is authorized in United States. It is also authorized in Israel.

Active ingredients

The drug NURTEC ODT contains one active pharmaceutical ingredient (API):

1	Rimegepant UNII 1383NM3Q0H - RIMEGEPANT SULFATE
	Rimegepant selectively binds with high affinity to the human calcitonin gene-related peptide (CGRP) receptor and antagonizes CGRP receptor function. The relationship between pharmacodynamic activity and the mechanism(s) by which rimegepant exerts its clinical effects is unknown.
	Read more about Rimegepant

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NURTEC ODT Orally disintegrating tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02CD06		N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CD Calcitonin gene-related peptide (CGRP) antagonists
Discover more medicines within N02CD06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
IL	מִשְׂרַד הַבְּרִיאוּת	8957
US	FDA, National Drug Code	72618-3000